US Supreme Court to hear oral arguments in Medtronic v Boston Scientific

Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

US Supreme Court to hear oral arguments in Medtronic v Boston Scientific

The US Supreme Court will hear oral arguments today in a case which may shed light on who has the burden of proof when a patent licensee is accused of infringing the patent.

In Medtronic v Boston Scientific, the court will consider whether a licensee challenging a declaratory judgment must demonstrate that its product does not infringe, or whether the patent holder must prove there was infringement.

The case concerns a device manufactured by Medtronic which treats heart failure, known as cardiac resynchronisation therapy (CRT). The patent is owned by Mirowski Family Ventures, which licensed it to another company called Guidant. In 1991, Medtronic sublicensed the patent to Eli Lilly, which had taken over from Guidant as the party-in-interest.

In 2007, Mirowski claimed several Medtronic products infringed the patents. Medtronic sued for a declaratory judgment of non-infringement.

In all other patent litigation, including other declaratory judgments, the burden of proving infringement is on the patent owner. But in September last year, the Federal Circuit ruled that Medtronic had the burden of proving it did not infringe, because it had brought the action for a declaratory judgment and because it was the licensee.

The Federal Circuit said that since the only remedy sought by Medtronic was having a court declare the products in question to be non-infringing, Medtronic should bear the burden of proving it is entitled to such relief.

“A contrary result would allow licensees to use MedImmune’s shield as a sword—haling licensors into court and forcing them to assert and prove what had already been resolved by license,” wrote Judge Richard Linn on behalf of the panel.

The decision overturned a ruling by the District Court for the District of Delaware, which upheld the validity of the patents but concluded that Medtronic did not infringe.

Medtronic appealed to the Supreme Court in March this year, and the court agreed to hear the case in May.

more from across site and SHARED ros bottom lb

More from across our site

Florina Firaru discusses making new connections, the art of flower arranging, and the biggest misconception about IP
The firm, which appointed three IP partners from A&O Shearman, wants to develop a tier one practice in Europe
The England and Wales appeals court handed down its judgment just seven working days after hearing the trademark dispute involving pharma company Merck
A host of law firms from across Europe and beyond helped bring the streaming technology dispute to a close
Hugues Derème, director general of the Benelux IP Office, unveils his vision for the region, how to improve IP awareness, and use of AI
A copyright win for AI firm Anthropic and a new executive order against law firm Jenner & Block were also among the top talking points this week
A principal at Schwegman Lundberg & Woessner explains how AI tools, including DeepIP, can position the firm to help clients
The firm explains why AI-empowered data analytics could make it a more efficient advocate for its clients
Penelope Aspinall, of IP wellbeing charity Jonathan’s Voice, explains why managers should take a three-tiered approach to looking after workers’ mental health
Heath Hoglund talks about the value proposition of patent pools and why it went ahead with its first-ever series of pool meetings in China
Gift this article